Fighting diseases of global impact
The Institute for Glycomics, founded 20 years ago, was so named due to its multidisciplinary research approach centred around glycomics.
Our unique research expertise makes us the only institute of its kind in Australia and only one of a handful in the world. We seek to collaborate with leading scientists around the world to build a critical mass around this multidisciplinary research. Global collaboration is essential to achieving our vision to bring forward novel drugs and vaccines to the community.
Welcome to the Institute for Glycomics
What is glycomics?
Glycomics is the study of the carbohydrate or sugar language within our body, referred to as the ‘glycome’. Every cell in our body is decorated with these sugars, which are essential to our health and wellbeing.
These simple sugar molecules connect together to create powerful structures called ‘glycans’. Cancers and infectious diseases can take advantage of glycans, resulting in major health problems and potentially death.
The study of sugars – glycomics – is a relatively new field of study compared with genomics (the study of genes) and proteomics (the study of proteins). However, glycomics is now a rising star thanks to the development of new tools to effectively identify sugar structures and their involvement in disease.
Our research focusses on the role that sugars play in disease and, using that knowledge, invent new drugs, vaccines and diagnostics to treat, prevent or diagnose cancer and infectious diseases.
“To be a world-leader in the discovery and development of drugs, vaccines and diagnostics through the application of innovative multidisciplinary science in a unique research environment.”
“Fighting diseases of global impact through discovery and translational science.”
A major research theme is discovering the role that sugars/carbohydrates play in disease and use that knowledge to develop new drugs and vaccines which will interfere with the biological process of disease. We provide a multidisciplinary approach to research and education, spanning medicinal and computational chemistry, various biological and physical sciences. This approach presents an exciting platform for the control of a wide-range of medical conditions such as infectious disease, cancer and other disorders.
Celebrating 20 years
2020 marks our 20th Anniversary year: 20 years of remarkable research
THE GLYCOMICS TRIBUNE
Our quarterly newsletter
We’re delighted to share with you our newly established quarterly newsletter, The Glycomics Tribune, where we aim to update you on our latest news, research projects, events, and special achievements here at the Institute for Glycomics.
To read our April to June 2020 newsletter, click here.
If you would like to subscribe to our quarterly newsletter you can do so through the 'STAY UP TO DATE' form at the bottom of this page.
Understanding enzymes linked to neurodegeneration and antiviral defence focus...
03 Aug 2020
Structural biologist Dr Thomas Ve from the Institute for Glycomics has been awarded an Australian...
ARC awards four Future Fellowships at Griffith
30 Jul 2020
Four Griffith University researchers have been awarded Australian Research Council (ARC) Future...
Researchers from Institute for Glycomics fight antibiotic-resistant gonorrhoea
24 Jun 2020
A research project by Griffith University’s Institute for Glycomics seeks to identify and develop...
Bendigo Bank Paradise Point joins the fight against COVID-19 by supporting...
18 Jun 2020
Bendigo Bank Paradise Point Community Bank Branch, long-standing supporters of Griffith...
New approaches to a COVID-19 treatment
17 Jun 2020
Australian research into the use of convalescent plasma in clinical trials for the prevention and...
$200,000 funding boost strengthens the Australian–German alliance iCAIR® fight...
15 Jun 2020
Australian and German researchers from the international consortium iCAIR® (Fraunhofer...